Literature DB >> 2900355

Gene studies in newborn males with Duchenne muscular dystrophy detected by neonatal screening.

C R Greenberg1, M Rohringer, H K Jacobs, N Averill, E Nylen, G J van Ommen, K Wrogemann.   

Abstract

18,000 newborn males were screened for Duchenne muscular dystrophy (DMD) by creatine kinase (CK) analysis of filter paper blood spots between Jan 1, 1986, and Dec 31, 1987. 5 affected boys have been identified, and in 3 of 5 probands molecular deletions or duplications have been found. 3 of 5 mothers were judged highly likely to be carriers of DMD because of repeatedly raised CK levels, identified gene rearrangements, or both abnormalities. 1 mother has a very low probability of being a carrier and 1 is at an intermediate risk. The use of DNA analyses in new DMD probands identified by neonatal screening has allowed confirmation of the diagnosis and accurate assignment of carrier status in mothers and female relatives in over half the cases studied, and may help to reduce the population incidence of DMD by avoiding delay before clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900355     DOI: 10.1016/s0140-6736(88)90414-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation.

Authors:  X Y Hu; P N Ray; E G Murphy; M W Thompson; R G Worton
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

Review 2.  Prenatal diagnosis of Duchenne muscular dystrophy: a three-year experience in a rapidly evolving field.

Authors:  E Bakker; E J Bonten; H Veenema; J T den Dunnen; P M Grootscholten; G J van Ommen; P L Pearson
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).

Authors:  Stuart J Moat; Donald M Bradley; Rachel Salmon; Angus Clarke; Louise Hartley
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

4.  Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.

Authors:  E Hildes; H K Jacobs; A Cameron; S S Seshia; F Booth; J A Evans; K Wrogemann; C R Greenberg
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

Review 5.  Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis.

Authors:  Salvatore Crisafulli; Janet Sultana; Andrea Fontana; Francesco Salvo; Sonia Messina; Gianluca Trifirò
Journal:  Orphanet J Rare Dis       Date:  2020-06-05       Impact factor: 4.123

6.  Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy.

Authors:  Sunju Park; Breanne Maloney; Michele Caggana; Norma P Tavakoli
Journal:  Muscle Nerve       Date:  2022-04-06       Impact factor: 3.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.